Temenos (TEMN) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
19 Jan, 2026Executive summary
Q3-24 saw stable global sales, strong customer engagement, and 61 product go-lives, but sales execution issues in Middle East & Africa impacted software licensing revenue, which reached $96.4M.
Leadership changes included the appointment of Barb Morgan as Chief Product and Technology Officer, with efficiency programs and organizational changes underway.
CHF 200M ($200M) share buyback completed, representing 4.3% of share capital.
Industry recognition includes top rankings in core banking and digital channels by IBS and IDC.
Strategic, operational, and financial plan review nearly completed, with updates expected at Capital Markets Day.
Financial highlights
Q3-24 ARR reached $760.9M, up 9% year-over-year, now 85% of product revenue and 75% of total revenue LTM.
Total revenue grew 4% year-over-year to $246.9M; EBIT rose 19% to $71.3M, with margin expanding by 4 points to 28.9%.
Free cash flow was $21.8M, down 21% year-over-year due to investigation payments; adjusted, it grew 26%.
EPS increased 25% year-over-year in Q3-24; non-IFRS EPS at $0.76, IFRS EPS at $0.43.
SaaS ACV was $9.4M; SaaS revenue up 5%; maintenance revenue up 10%; subscription revenue up 17-19%.
Outlook and guidance
FY-24 guidance revised: ARR growth now 11%-12% (was ~13%), total software licensing flattish (was 3%-6%), FCF growth at least 12% (was at least 16%).
EBIT and EPS guidance for the year unchanged; EBIT expected to grow 7%-9%, EPS 6%-8%.
Q4-24 software licensing growth expected at ~5%.
Tax rate expected to remain 20%-22%.
Midterm targets to be revisited at Capital Markets Day in November.
Latest events from Temenos
- Upgraded 2028 targets: ARR above $1.23B, recurring revenue, and strong AI-driven U.S. growth.TEMN
CMD 202625 Feb 2026 - Double-digit growth, raised long-term targets, and strong cash flow with share buyback and dividend.TEMN
Q4 202524 Feb 2026 - Q2-24 saw 12% ARR growth, 8% higher EPS, and revised FY-24 guidance after sales delays.TEMN
Q2 20243 Feb 2026 - Q2-25 delivered strong growth in revenue, profit, and ARR, prompting a raised FY-25 outlook.TEMN
Q2 202520 Jan 2026 - Q1-25 saw strong ARR, EBIT, and cash flow growth, with FY-25 guidance and CHF 250m buyback confirmed.TEMN
Q1 202520 Jan 2026 - Q3 2025 delivered double-digit growth, raised guidance, and completed a major share buyback.TEMN
Q3 202520 Jan 2026 - FY-28 targets: ARR > $1.3bn, EBIT $500m, FCF $420m, driven by US and modular growth focus.TEMN
CMD 202415 Jan 2026 - Q4-24 and FY-24 saw robust ARR and cash flow growth, with a strong outlook post-Multifonds sale.TEMN
Q4 202416 Dec 2025